Overview on Epigenetic Re-programming: A Potential Therapeutic Intervention in Triple Negative Breast Cancers

Breast cancer treatments leads to variable responses. Hormonal therapy is beneficial to receptor positive breast cancer subtypes and display better clinical outcome than triple negative breast cancers (TNBCs) with FEC (5-Fluorouracil, Epirubicin and Cyclophosphamide) the mainstay chemotherapy regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanif, Ezanee Azlina Mohamad, Shah, Shamsul Azhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428526/
https://www.ncbi.nlm.nih.gov/pubmed/30583339
http://dx.doi.org/10.31557/APJCP.2018.19.12.3341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428526/
https://www.ncbi.nlm.nih.gov/pubmed/30583339
http://dx.doi.org/10.31557/APJCP.2018.19.12.3341

Ejemplares similares